MoneyWorks4Me

FDC - Quaterly Results

28 May 2026 Evaluate
The revenue zoomed 17.09% to Rs. 5643.64 millions for the quarter ended March 2026 as compared to Rs. 4820.04 millions during the corresponding quarter last year.Net Profit witnessed a 122.07% growth almost the double from Rs. 482.15 millions to Rs. 1070.70  millions  of same quarter last year.The company reported a good operating profit of 1587.76 millions compared to 842.52 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5643.64 4820.04 17.09 21263.27 20701.12 2.72 21263.27 20701.12 2.72
Other Income 471.64 314.26 50.08 1110.01 1055.18 5.20 1110.01 1055.18 5.20
PBIDT 1587.76 842.52 88.45 4631.81 4257.65 8.79 4631.81 4257.65 8.79
Interest 14.99 11.82 26.82 49.24 44.88 9.71 49.24 44.88 9.71
PBDT 1572.77 830.70 89.33 4374.68 4212.77 3.84 4374.68 4212.77 3.84
Depreciation 143.13 155.29 -7.83 591.04 536.06 10.26 591.04 536.06 10.26
PBT 1429.64 675.41 111.67 3783.64 3676.71 2.91 3783.64 3676.71 2.91
TAX 358.94 193.26 85.73 924.40 940.46 -1.71 924.40 940.46 -1.71
Deferred Tax 48.94 37.36 31.00 61.40 90.46 -32.12 61.40 90.46 -32.12
PAT 1070.70 482.15 122.07 2859.24 2736.25 4.49 2859.24 2736.25 4.49
Equity 162.81 162.81 0.00 162.81 162.81 0.00 162.81 162.81 0.00
PBIDTM(%) 28.13 17.48 60.95 21.78 20.57 5.91 21.78 20.57 5.91
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..